Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

 

 
Our objective is to understand temporal trends in opioid-related crime incidents and the comparability with the dynamic patterns in health-related outcomes.
Original research | 2022
About PWUD, Crime, Illegal drugs
Among hospitalized patients with injection drug use-associated infective endocarditis (IDU-IE) at the two tertiary-care hospitals in the Canadian Maritimes, we aimed to identify (1) the availability o
Original research | 2022
Wrap-around services, About prescribers, Outcomes, Illegal drugs, Small/medium cities, Substitution/OAT, Transitions in care/treatment, Hospitals
The goal of this study was to validate the performance of the Tobacco, Alcohol, Prescription medication, and other Substance use (TAPS) tool in community pharmacy settings compared to a reference-stan
Original research | 2021
About pharmacists, Illegal drugs, Stimulants
Individuals with OUD-associated endocarditis require long periods of complex medical care, often face recurrent addiction- and infection-related complications, and have dismal clinical outcomes.
Original research | 2020
About PWUD, Barriers and enablers, Illegal drugs, Substitution/OAT, Injecting drugs, Stigma, Hospitals
Includes harm reduction tips
Handout | 2013
Withdrawal, Harm reduction, About PWUD, Illegal drugs, 2SLGBTQI+, Stimulants, Sex/Gender
Short visual summary of Blood Ties' "Don't Be An A**hole" best practices report
Infographic | 2018
Clinical guidance, Wrap-around services, Equity, About prescribers, About PWUD, Social services, Barriers and enablers, Indigenous, Small/medium cities, Stigma

We assessed the adoption of increased take-home medication during COVID-19 and whether increased take-home doses is associated with clients' characteristics.

Original research | 2022
Policy/Regulatory, About PWUD, Illegal drugs, Substitution/OAT, Carries/take-home doses
Subgroups within the diverse methamphetamine-using population may have distinct treatment needs.
Original research | 2022
Overdose, Harm reduction, Equity, About PWUD, Outcomes, Poverty, Illegal drugs, Stimulants
Outlines key themes found among people who use drugs about their experiences with various health and social service agencies and providers in Whitehorse
Report | 2018
Clinical guidance, Wrap-around services, Equity, About prescribers, About PWUD, Social services, Barriers and enablers, Indigenous, Small/medium cities, Stigma

This report summarizes all unintentional illicit drug toxicity deaths in British Columbia (accidental and undetermined) that occurred between

Report | 2022
Overdose, Mortality, Evidence base, Safer supply, About PWUD, Outcomes, Illegal drugs, Small/medium cities, Sex/Gender
In Kyrgyzstan, an estimated 35% of people in prison are PWID, and 10% have been diagnosed with HIV.
Original research | 2021
About PWUD, Outcomes, Legal system/law enforcement, Substitution/OAT
As Colorado ranked among the top nationally in non-medical use of opioids, a pilot medication for opioid use disorder (MOUD) program was developed to increase the number of NPs and PAs providing MOUD
Original research | 2022
Evidence base, Safer supply, About PWUD, Outcomes, Chronic pain, Mental health
Webpage | 2021
Peer/PWLLE program involvement
Cocaine use contines to be a significant public health problem world-wide.
Commentary | 2020
Illegal drugs, Stimulants
Shared decision-making (SDM) refers to the collaboration between patients and their healthcare providers to make clinical decisions based on evidence and patient preferences, often supported by patien
Original research | 2021
Hesitancy of prescribers , About prescribers, Hospitals
Substance use disorder researchers and treatment professionals have long recognized that risk of opioid-related mortality (ORM) is elevated after release from jail and prison.
Original research | 2021
Overdose, Mortality, Equity, About PWUD, Social services, Outcomes, Legal system/law enforcement, Illegal drugs
To evaluate the effectiveness of an innovative opioid overdose prevention program (OOPP), with changes in knowledge and attitudes serving as the primary outcome measures.
Original research | 2022
Overdose, Harm reduction, About prescribers, Stigma
One known barrier to MOUD retention is stigma, particularly within ethno-racial minority communities.
Original research | 2022
About PWUD, Barriers and enablers, Substitution/OAT, Peer/PWLLE program involvement, Stigma

Barriers to, and facilitators of, OST patients’ healthcare seeking have been sparsely examined.

Original research | 2022
Wrap-around services, Barriers and enablers, About PWUD, Substitution/OAT, Stigma

The study used mixed methods to assess the feasibility, acceptability and accessibility of a peer-delivered, relational intervention to reduce harms and improve health/well-being, quality of life a

Original research | 2022
Peer/PWLLE program involvement, Wrap-around services

Affiner votre recherche

Mots clés
Format
Région